Initiation of anticoagulation in atrial fibrillation: which factors are associated with choice of anticoagulant?

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Safety of non-vitamin K antagonist oral anticoagulants - coronary risks

(2016) Daniel Caldeira et al.   Expert Opinion On Drug Safety

Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke

(2016) Jonathan C. Hsu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries

(2016) Seo Hyon Baik et al.   Journal of Managed Care & Specialty Pharmacy

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark

(2016) Laila Staerk et al.   Scientific Reports

Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation— Quality and Cost Implications

(2014) Nihar R. Desai et al.   AMERICAN JOURNAL OF MEDICINE

Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis

(2014) Azza AbuDagga et al.   BMC HEALTH SERVICES RESEARCH

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

(2014) Craig T. January et al.   CIRCULATION

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013

(2014) J. B. Olesen et al.   EUROPACE

Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials

(2014) Jonathan Douxfils et al.   Journal of the American Heart Association

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

(2013) Rikke Sørensen et al.   BMJ Open

Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

(2013) Benjamin A. Steinberg et al.   Journal of the American Heart Association

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

(2012) Stefan H. Hohnloser et al.   CIRCULATION

Oral anticoagulation use by patients with atrial fibrillation in Germany

(2012) Antje Groth et al.   THROMBOSIS AND HAEMOSTASIS

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE